Children's Mercy Kansas City

SHARE @ Children's Mercy
Manuscripts, Articles, Book Chapters and Other Papers
5-2014

A refresher on Tourette syndrome.
James R. Batterson
Children's Mercy Hospital

Shayla Sullivant
Children's Mercy Hospital

Jean-Baptist LePichon
Children's Mercy Hospital

Christy Kleinsorge
Children's Mercy Hospital

Sandy Price
Children's Mercy Hospital

See next page for additional authors

Follow this and additional works at: https://scholarlyexchange.childrensmercy.org/papers
Part of the Behavioral Medicine Commons, and the Neurology Commons

Recommended Citation
Batterson, J. R., Sullivant, S., LePichon, J., Kleinsorge, C., Price, S., Andrews, S. A refresher on Tourette
syndrome. Missouri medicine 111, 202-206 (2014).

This Article is brought to you for free and open access by SHARE @ Children's Mercy. It has been accepted for
inclusion in Manuscripts, Articles, Book Chapters and Other Papers by an authorized administrator of SHARE @
Children's Mercy. For more information, please contact library@cmh.edu.

Creator(s)
James R. Batterson, Shayla Sullivant, Jean-Baptist LePichon, Christy Kleinsorge, Sandy Price, and
Stephanie Andrews

This article is available at SHARE @ Children's Mercy: https://scholarlyexchange.childrensmercy.org/papers/1817
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ZĞĨƌĞƐŚĞƌŽŶdŽƵƌĞƩĞ^ǇŶĚƌŽŵĞ
ďǇ:ĂŵĞƐZ͘ĂƩĞƌƐŽŶ͕D͕^ŚĂǇůĂ^ƵůůŝǀĂŶƚ͕D͕:͘͘>ĞWŝĐŚŽŶ͕D͕ŚƌŝƐƚǇ<ůĞŝŶƐŽƌŐĞ͕WŚ͕
^ĂŶĚǇWƌŝĐĞ͕ZEΘ^ƚĞƉŚĂŶŝĞŶĚƌĞǁƐ͕D^t

dŽƵƌĞƩĞŝƐŽƌĚĞƌŝƐ
ĐŚĂƌĂĐƚĞƌŝǌĞĚďǇĂ
ĐŽŵďŝŶĂƟŽŶŽĨǀŽĐĂů
ĂŶĚŵŽƚŽƌƟĐƐƚŚĂƚĂƌĞ
ƉƌĞƐĞŶƚĨŽƌĂƚůĞĂƐƚŽŶĞ
ǇĞĂƌĂŶĚŶŽƚĂƩƌŝďƵƚĂďůĞ
to a substance or other
ŵĞĚŝĐĂůĐŽŶĚŝƟŽŶ͘

Abstract
Tourette Syndrome (TS) is
recognized as a more common
neurodevelopmental disorder
than once thought. In this
article we present an update
on TS including the DSM-5
revised criteria, new ﬁndings
in the genetics of TS, treatment
advances such as new medications
for tics and the use of new tools
including Cognitive Behavioral
Intervention for Tics (CBIT). We
also explore supportive services
for the ongoing care of patients
using nursing education and
family therapy.

/ŶƚƌŽĚƵĐƟŽŶ
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Tourette Syndrome (TS) has
been a recognized medical condition
for over 125 years and is included
in DSM-5 in the ﬁrst chapter on
Neurodevelopmental Disorders.1
The diagnosis, known as Tourette
Disorder, is characterized by a
combination of vocal and motor tics
that are present for at least one year
and “not attributable to a substance
or other medical condition.”1 A
tic is a “sudden, rapid, recurrent,
non-rhythmic motor movement or
vocalization”.1,2 The diagnosis in DSM5 contains only minor changes from
DSM-4 TR, which include removal of
the word “stereotyped” to describe

tics. DSM-4 TR also required that
tics not disappear for greater than
three months and that statement is
no longer included in DSM-5. The
condition is often known to wax and
wane from early childhood through
adolescence, then improves in early
adulthood. Some patients continue
to suffer from more pronounced tics
for much of their life. Though it has
been claimed that Mozart had TS,
more recent evidence has rebuffed
this claim.2 Historical ﬁgures including
Samuel Johnson probably would have
satisﬁed diagnostic criteria, however,
and Jim Eisenreich, a well known
baseball player, uses his TS diagnosis to
educate others.

d^ƉŝĚĞŵŝŽůŽŐǇ
According to the Mental Health
Surveillance Among Children study
published by the CDC in 2013, the
prevalence of TS is 0.35% among
children 6 to 17 years of age3. The
prevalence in boys is twice as high as
it is in girls (0.4% versus 0.2%). These
are almost certainly underestimates,
as TS often presents before the age
of six and estimated prevalence
rates were derived from parental
reports that their child had ever been
diagnosed with TS. A meta-analysis
of 35 studies found a prevalence of
0.77% overall and, when stratiﬁed
by gender, a prevalence of 1.06% in
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boys and 0.25% in girls.4 It is worth emphasizing that the
prevalence of transient tic disorder in the same study was
reported as 2.99%. TS and tic disorders occur at about
half the prevalence of depression and the same prevalence
as autism and are therefore a common problem in
childhood.3

Figure 1
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d^ŶǀŝƌŽŶŵĞŶƚĂůŽŶƚƌŝďƵƟŽŶƐ
There is little doubt that environmental factors
contribute to the pathophysiology of TS. In one study
of 60 patients with TS, there was a positive correlation
between minor stressful events in life and the severity
of tics.3 The role of autoimmune mechanisms remains
a topic of considerable debate. Over the last 20 years
the existence of entities such as PANDAS (Pediatric
Autoimmune Neuropsychiatric Disorder Associated
with Streptococcal infection) have been argued. Strictly
deﬁned, PANDAS is characterized by an explosion of
tics and severe Obsessive-Compulsive Disorder (OCD)
behaviors following a streptococcal infection that
usually resolves after a few weeks.5 There is convincing
evidence supporting the existence of PANDAS in a
minority of TS cases, yet the epidemiological studies
remain inconclusive.6 There is no evidence to support
prophylactic treatment with antibiotics at this time for
PANDAS and standard treatments are recommended for
TS and OCD regardless of etiology.4

d^'ĞŶĞƟĐŽŶƚƌŝďƵƟŽŶƐ
While environmental contributions to the
pathophysiology of TS remain debated, the genetic
contributions are becoming much better established. The
strongest evidence for a genetic basis for TS is gathered
from concordance studies among twins and ﬁrst-degree
relatives.7 For TS, the concordance among monozygotic
twins is as high as 56%, while it is 8% for dizygotic twins;
ﬁrst-degree relatives of patients with TS are 10 to 100
times more likely than the general population to develop
TS. Yet sorting out the speciﬁcs of the genes involved
is turning out to be much more complicated than may
have been anticipated from these studies. It is now very
clear that TS is a polygenetic disease, and multiple genes
are contributing to its pathophysiology. Various studies
have identiﬁed well over a dozen individual genes and
chromosomal regions through genome wide analysis
and searches for rare copy number variants in patients
with TS. An excellent review by Pashou on the genetics
of TS contains more detail.7,8 TS has important genetic
etiologies and as the contributions of various genes are

Tics

A
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ĚĂƉƚĞĚĨƌŽŵ:ĂŶŬŽǀŝĐŚ͕Ğƚ͘Ăů

elucidated, a new era in terms of its treatment will likely
emerge.

ŽͲDŽƌďŝĚŝƚǇ
Tourette Syndrome is frequently co-morbid with
certain psychiatric disorders. The most notable are
Attention-Deﬁcit/Hyperactivity Disorder (ADHD) and
(OCD).9,10 See Figure 1. Studies of the rates of comorbidity have shown widely varying results for both of
these disorders with some as high as 80-90% and others
as low as 10%.10,11,12 Recent ﬁndings show the lowest comorbidity rates are seen in the general population, and
higher rates of co-morbidity are found when clinically
referred patients are surveyed.13 In addition to OCD and
ADHD, rage attacks, sleep disturbances, depression and
stuttering were all found at a higher rate in patients with
TS than would be expected in the general population.10
Cognitive deﬁcits have been shown to be more common
in TS, especially in the realm of executive functions.14
Executive functioning is what helps an individual organize,
prioritize and plan. In a study by Kurlan et al., aggression
was found in 18.5% of patients with tics, and social
problems occurred for 24.5 % of patients with tics.12
The OCD that accompanies TS appears to have
different phenomenology from OCD alone. In the TS
patient, touching compulsions and an obsessive need for
symmetry are more commonly seen, along with a feeling
that sensations need to be “evened up.”4 OCD responds
less well to medication when tics are present than when
OCD occurs alone.11 Reasons for the higher rates of coMissouri Medicine | May/June 2014| 111:3 | 203
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morbidity with OCD and ADHD have yet to be clariﬁed.
Theories have included some structural areas of the brain
that the three have in common including the fronto-striatal
cortex as well as similarities in characteristics such as
disinhibition.10
An individual who has TS, ADHD and OCD may
experience unfortunate synergism among the conditions.
For example, anxiety associated with an obsession may
exacerbate tics and cause the attention span to further
deteriorate. It can be challenging at times to discern
which condition demands treatment ﬁrst. Even though
TS is known as a neurological disorder, mental health
professionals often prove a valuable addition to the
treatment team.

WŚĂƌŵĂĐŽůŽŐǇ
The presence of non-impairing tics, even if qualifying
for a TS diagnosis, does not demand treatment with
medication or other therapies. Examples of impairment
from tics include physical pain, difﬁculty performing
Activities of Daily Living, and ridicule by peers, which
can be detrimental to self-esteem. Assessing the level of
impairment allows an analysis of the risk beneﬁt ratio
regarding the use of medication. Behavioral approaches
such as Cognitive Behavior Interventions for Tics
(CBIT) and a cautious approach of monitoring without
medication are indicated in mild cases.15 For moderate
to severe tics and those that have not responded to CBIT,
or when therapy is not an option, medications should be
considered (See Table 1).8
Randomized, placebo-controlled trials of
medications to treat tics show reduction in symptoms
from 25-56%.16 The goal of medication is tic reduction
to improve functioning, but eradication of all tics is not
typically achieved. It is critical to balance the negative
side effects of treatment with the minimal impairment
that might be experienced from residual mild tics.16
Alpha agonists, although off label for TS, are often
used as ﬁrst line choices for treatment given their lower
propensity for side effects.15 They tend to have a lower
response rate at 30-37% than the dopamine antagonists.8
Clonidine has been used for over 30 years for tics
although it has limited empirical support.17 Guanfacine is
thought to be better tolerated but has limited evidence as
well. Both can contribute to headaches and somnolence
and can lead to rebound hypertension if stopped
abruptly. Kapvay® (clonidine) and Intuniv® (guanfacine)
are extended release formulations that have received
204 | 111:3 |May/June 2014 | Missouri Medicine

FDA indications for ADHD; however, they have not been
studied as treatment for tics.
While the ﬁrst generation antipsychotics haloperidol
and pimozide are FDA approved to treat tics in youth,
they are often second and third tier choices, as other
options are better tolerated. Pimozide carries a risk of
prolonging the QTc more than other antipsychotics used
to treat tics, and EKG’s are recommended at baseline and
with dosage increases.8 Haloperidol and pimozide can
lead to extrapyramidal symptoms as well as drowsiness
and carry the risk of tardive dyskinesia.17 Risperidone has
at least four controlled trials demonstrating effectiveness
in tic reduction, while studies on aripiprazole are
ongoing. Open label studies have shown that aripiprazole
and ziprasidone may help and they are used off-label. All
antipsychotics are associated with weight gain, but Second
Generation Antipsychotics (SGA) are associated with more
weight gain in children. Monitoring of fasting glucose and
lipids is recommended at baseline, at three months and
then annually for the SGAs. The risk of tardive dyskinesia is
present with SGAs as well.
Additional options include atomoxetine, a
norepinephrine reuptake inhibitor, which is FDA approved
to treat ADHD and is showing some early promise to
reduce tics.18 Topiramate also has one study showing
impressive tic reduction and is a novel approach when
traditional options have failed.19 Supplements including
Vitamin B6 and magnesium have some evidence but are
not yet considered standard treatment.
Standard treatments for OCD and ADHD should be
considered in the co-morbid patient. For ADHD in the
presence of tics, non-stimulants are a logical ﬁrst choice as
stimulants carry warnings about the risk of exacerbating
tics. The contraindication of stimulants for those with
tics has been brought into question with several studies
showing that tics do not always increase with stimulants.8
Even though OCD may not respond as well to SSRIs when
tics are present, the SSRI may still help some and Cognitive
Behavior Therapy (CBT) also remains a viable option for
these patients.

ŽŵƉƌĞŚĞŶƐŝǀĞĞŚĂǀŝŽƌ/ŶƚĞƌǀĞŶƟŽŶĨŽƌdŝĐƐ
Azrin and Nunn ﬁrst described15,18,19 Habit Reversal
Training (HRT) as an effective intervention for tics in
1973.20 HRT begins with psychoeducation regarding the
neurobiological nature of tics and emphasizes the fact that
while tics are not voluntary, it is possible to learn to alter
their expression. Primary components of HRT include
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Table 1
DĞĚŝĐĂƚŝŽŶ

^ƚĂƌƚŝŶŐĚŽƐĞ

DĂǆĚĂŝůǇ
ĚŽƐĞ

dŝŵŝŶŐŽĨĚŽƐĞ

^ƵŐŐĞƐƚĞĚDŽŶŝƚŽƌŝŶŐ

^ŝĚĞĞĨĨĞĐƚƐ

Guanfacine immediate
release

0.5mg

4mg

BID

Vitals at Dr. visits

Sedation

Guanfacine delayed
release
Clonidine Instant release
Clonidine delayed release

1mg
0.05mg
0.1mg

4mg
4mg
0.4mg

Daily
Bid or TID
BID

Vitals at Dr. visits
Vitals at Dr. visits
Vitals at Dr. visits

Sedation
Sedation
Sedation

Aripiprazole

2.5mg

15-30mg

Daily

Fasting lipids, Glucose, LFT,
Weight

Weight gain,
EPS

Risperidone

0.5mg

6mg

BID

Fasting lipids, Glucose, LFT,
Prolactin, Weight

Weight gain,
EPS

Atomoxetine

18mg

100mg

Daily

LFT if symptomatic

Haloperidol

0.075mg/kg

1.4mg/kg

Daily or BID

ECG

GI Upset
Weight gain,
EPS

Pimozide

1mg

10mg

Daily or BID

if >0.05 mg/kg need 2D6
genotyping, ECG

Topiramate
Fluphenazine

25mg
0.5 mg

200mg
3mg

BID
Daily

None
ECG

Ziprasidone

20mg w/food

160MG

BID

ECG,fasting lipids,glucose, LFT

Awareness Training and use of Competing Responses.20
More recently, Comprehensive Behavioral Intervention for
Tics (CBIT), a version of HRT speciﬁc to Tourette Disorder,
has been developed. CBIT includes Awareness Training
and use of Competing Responses, as well as a FunctionBased Intervention, which addresses environmental factors
inﬂuencing tic severity. CBIT is designed to teach its three
core components in a series of 8 therapy sessions that occur
over a 10-week period.21
Awareness Training emphasizes developing insight and
awareness of premonitory urges and tic occurrence through
self-monitoring. For example, children might practice
the tic, or an approximation of the tic, while watching
themselves in a mirror and paying attention to the muscles
involved. In addition, keeping track of each occurrence
of the tic helps to build awareness. For children, low-key
prompts from caregivers are an essential part of developing
awareness. Competing Responses provide children with
alternate behaviors to engage in that are incompatible with
the tic. For example, children with a leg lifting tic could be
taught to push their feet into the ﬂoor rather than lifting
their leg, and children with a tic involving head movements
might be taught to tighten their neck muscles and hold their
heads straight. The purpose of Function-Based Intervention
is to identify antecedents and consequences that make

Weight gain,
EPS
Cognitive
dulling
Risk of TD
Weight gain,
EPS

tics more likely to happen and that negatively impact the
child’s functioning. Such factors are identiﬁed and then
modiﬁed in order to reduce the likelihood of future tics
and improve the child’s ability to function. For example,
if a child struggles with academics and experiences
worsened tics at homework time, parents might decide
to discontinue their homework time, inadvertently
reinforcing the tic. CBIT therapists help families address
sources of stress and reduce or eliminate secondary gain.
If a child is teased by peers, thereby increasing their
stress and anxiety, a therapist would help the school
educate peers regarding the non-contagious, involuntary,
neurological nature of tics, with a goal of reducing or
eliminating teasing.
CBIT has been found to yield a signiﬁcant decrease in
tic severity that maintained over time in two randomized,
controlled trials.22 In their 2010 study, Piacentini and
colleagues studied 126 children and adolescents with
TS and found CBIT produced greater tic reduction than
did supportive therapy and education.22,23 It is important
to note that many of these children were already on
psychotropic medication and still demonstrated beneﬁt
from CBIT.22 Given the very promising results of recent
studies, increasing knowledge of the effectiveness of
CBIT and the availability of psychologists and other
Missouri Medicine | May/June 2014| 111:3 | 205
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mental health providers with training in CBIT has
become a primary goal of the National Tourette Syndrome
Association.22

SƵƉƉŽƌƟǀĞ^ĞƌǀŝĐĞƐ
The families of children with TS are met with
great challenges. These children may display problems
with adapting to aspects of the environment, have a
higher level of emotional responses, or have a higher
level of activity, all the while looking like the little girl
or boy that lives next door. “It is therefore imperative
to identify methods to deal constructively with those
characteristics that make caring for children with TS so
difﬁcult.”24 Parents often feel lacking in the ability to
educate schools and family members about the disorder
and the speciﬁc needs of their child, leading to feelings
of inadequacy as a parent. Skill sets used with other
children do not always seem to have impact on these
children. Due to the complexity of the disorder, nursing
staff in our Tourette Clinic have been educated about tics,
behavioral presentations, interventions and medications
used to treat the disorder. The nursing staff can then
assist in providing not only advocacy for the patient/
family but also an avenue for the parent to be allowed to
verbalize thoughts, feelings, and concerns without fear
of judgment, thereby potentially providing a sense of
validation.
Family therapy is an integral component in providing
comprehensive services to families and children affected
by TS, especially in the presence of co-morbid disorders.
Ross Greene describes the difﬁculties with adaptation
to change in their environments and transitions causing
many of these children to have highly explosive, reactive
behaviors and that these children “…can lay bare many
family issues that might never have risen to the surface
had the parents been blessed with a less difﬁcult child.”25

ŽŶĐůƵƐŝŽŶ
In the Division of Developmental & Behavioral
Sciences at Children’s Mercy Hospital, we recognize that
patients with TS often need a multidisciplinary approach
to treatment. This is especially true with those who
suffer from co-morbid OCD and ADHD along with their
TS. While we have been treating TS for many years,
our newly established TS Clinic will involve psychiatry,
neurology, psychology, nursing and family therapists to
provide the holistic care needed for these patients.
206 | 111:3 |May/June 2014 | Missouri Medicine
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